These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2802553)

  • 21. Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
    McIlleron H; Wash P; Burger A; Norman J; Folb PI; Smith P
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1170-7. PubMed ID: 16569826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
    Park JS; Lee JY; Lee YJ; Kim SJ; Cho YJ; Yoon HI; Lee CT; Song J; Lee JH
    Antimicrob Agents Chemother; 2016 Jan; 60(1):92-8. PubMed ID: 26459901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
    Uttley AH; Collins CH
    Tubercle; 1988 Sep; 69(3):193-5. PubMed ID: 3151140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of antibacterial preparations on growth of Mycobacterium tuberculosis in a model of primary tuberculous infection in tissue culture].
    Kunichan AD; Sokolova GB; Shapatava MN
    Probl Tuberk; 1994; (5):40-3. PubMed ID: 7870726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3.
    Crowle AJ; May MH
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2217-22. PubMed ID: 2127346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
    Heifets L
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
    Eltringham IJ; Wilson SM; Drobniewski FA
    J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
    Paramasivan CN; Herbert D; Prabhakar R
    Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
    Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
    Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.
    Hu Y; Pertinez H; Ortega-Muro F; Alameda-Martin L; Liu Y; Schipani A; Davies G; Coates A
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4778-85. PubMed ID: 27216065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
    Rosenthal IM; Williams K; Tyagi S; Peloquin CA; Vernon AA; Bishai WR; Grosset JH; Nuermberger EL
    Am J Respir Crit Care Med; 2006 Jul; 174(1):94-101. PubMed ID: 16574936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic.
    Crowle AJ; Dahl R; Ross E; May MH
    Infect Immun; 1991 May; 59(5):1823-31. PubMed ID: 1902198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
    Bergmann JS; Woods GL
    J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro.
    Zeis BM
    Chemotherapy; 1988; 34(1):56-60. PubMed ID: 2832129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effect of rifampin on mycobacteria.
    Lorian V; Finland M
    Appl Microbiol; 1969 Feb; 17(2):202-7. PubMed ID: 4975656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.